Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Current Hematologic Malignancy Reports|January 26, 2020
Moving Past Ganciclovir and Foscarnet: Advances in CMV TherapyMorgan HakkiCurrent Opinion in Infectious Diseases|October 18, 2011
The biology of cytomegalovirus drug resistanceMorgan Hakki, Sunwen ChouJac-Antimicrobial Resistance|October 18, 2021
Emergence of non-susceptibility during persistent <i>Pseudomonas aeruginosa</i> bacteraemia in haematopoietic cell transplant recipients and haematological malignancy patientsLauren Fontana, Morgan HakkiVirology|September 2, 2008
Cellular serine/threonine phosphatase activity during human cytomegalovirus infectionMorgan Hakki, Adam P GeballeInfection|February 21, 2018
Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipientsMorgan Hakki, James S LewisJournal of Virology|May 28, 2005
Double-stranded RNA binding by human cytomegalovirus pTRS1Morgan Hakki, Adam P GeballeAntiviral Research|June 6, 2012
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivoSunwen Chou, Morgan Hakki, Stephen VillanoBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell TransplantationJenna Petersen, Christian Lindner, Morgan HakkiInfectious Disease Clinics of North America|May 15, 2010
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman, Morgan Hakki, Michael BoeckhHematology/Oncology Clinics of North America|January 18, 2011
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman, Morgan Hakki, Michael BoeckhPageof 4